Panacea Healthcare & Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-06-2024
- Paid Up Capital ₹ 5.00 M
as on 17-06-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 17-06-2024
- Satisfied Charges ₹ 5.25 M
as on 17-06-2024
- Revenue 11.43%
(FY 2023)
- Profit -4.12%
(FY 2023)
- Ebitda -5.90%
(FY 2023)
- Net Worth 27.25%
(FY 2023)
- Total Assets -18.98%
(FY 2023)
About Panacea Healthcare & Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹5.25 M, as per Ministry of Corporate Affairs (MCA) records.
Sadhna Bharti and Gopal Bharti serve as directors at the Company.
- CIN/LLPIN
U85110HR2015PTC057177
- Company No.
057177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2015
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Panacea Healthcare & Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Bharti  | Director | 05-Nov-2015 | Current |
| Sadhna Bharti | Director | 05-Nov-2015 | Current |
Financial Performance of Panacea Healthcare & Diagnostics.
Panacea Healthcare & Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.43% increase. The company also saw a slight decrease in profitability, with a 4.12% decrease in profit. The company's net worth Soared by an impressive increase of 27.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panacea Healthcare & Diagnostics?
In 2023, Panacea Healthcare & Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Jun 2022 | ₹2.50 M | Open |
Others Creation Date: 15 Sep 2016 | ₹5.25 M | Satisfied |
How Many Employees Work at Panacea Healthcare & Diagnostics?
Panacea Healthcare & Diagnostics has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panacea Healthcare & Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Healthcare & Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
